Practice Changing: High-Dose Radiation Not Superior in NSCLC

Non-small cell lung carcinomaImage via WikipediaPractice Changing: High-Dose Radiation Not Superior in NSCLC


A landmark trial in nonsmall-cell lung cancer (NSCLC) has found that high-dose conformal radiotherapy (74 Gy) did not improve survival, compared with the standard dose (60 Gy), in patients with unresectable stage III disease.
In fact, median overall survival was better with the standard dose than with the high dose...........


Enhanced by Zemanta

Populární příspěvky z tohoto blogu

Synoviální sarkom

Implatabilní port

Paraneoplázie